These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 17166319

  • 1. Immune system pathogenesis is prevented by the neutralization of the systemic trans-sialidase from Trypanosoma cruzi during severe infections.
    Risso MG, Pitcovsky TA, Caccuri RL, Campetella O, Leguizamón MS.
    Parasitology; 2007 Apr; 134(Pt 4):503-10. PubMed ID: 17166319
    [Abstract] [Full Text] [Related]

  • 2. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH, De Vusser K, Laroy W, Daurelio L, Nocito AL, Revelli S, Contreras R.
    Vaccine; 2008 May 02; 26(19):2322-34. PubMed ID: 18403070
    [Abstract] [Full Text] [Related]

  • 3. Differential expression of a virulence factor, the trans-sialidase, by the main Trypanosoma cruzi phylogenetic lineages.
    Risso MG, Garbarino GB, Mocetti E, Campetella O, Gonzalez Cappa SM, Buscaglia CA, Leguizamon MS.
    J Infect Dis; 2004 Jun 15; 189(12):2250-9. PubMed ID: 15181573
    [Abstract] [Full Text] [Related]

  • 4. Trans-sialidase from Trypanosoma cruzi induces apoptosis in cells from the immune system in vivo.
    Leguizamón MS, Mocetti E, García Rivello H, Argibay P, Campetella O.
    J Infect Dis; 1999 Oct 15; 180(4):1398-402. PubMed ID: 10479182
    [Abstract] [Full Text] [Related]

  • 5. Thymocyte depletion in Trypanosoma cruzi infection is mediated by trans-sialidase-induced apoptosis on nurse cells complex.
    Mucci J, Hidalgo A, Mocetti E, Argibay PF, Leguizamon MS, Campetella O.
    Proc Natl Acad Sci U S A; 2002 Mar 19; 99(6):3896-901. PubMed ID: 11891302
    [Abstract] [Full Text] [Related]

  • 6. In vivo infection by Trypanosoma cruzi: the conserved FLY domain of the gp85/trans-sialidase family potentiates host infection.
    Tonelli RR, Torrecilhas AC, Jacysyn JF, Juliano MA, Colli W, Alves MJ.
    Parasitology; 2011 Apr 19; 138(4):481-92. PubMed ID: 21040619
    [Abstract] [Full Text] [Related]

  • 7. The trans-sialidase from Trypanosoma cruzi triggers apoptosis by target cell sialylation.
    Mucci J, Risso MG, Leguizamón MS, Frasch AC, Campetella O.
    Cell Microbiol; 2006 Jul 19; 8(7):1086-95. PubMed ID: 16819962
    [Abstract] [Full Text] [Related]

  • 8. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes.
    Duthie MS, Cetron MS, Van Voorhis WC, Kahn SJ.
    Acta Trop; 2005 Mar 19; 93(3):317-29. PubMed ID: 15725381
    [Abstract] [Full Text] [Related]

  • 9. Antibodies inhibiting Trypanosoma cruzi trans-sialidase activity in sera from human infections.
    Leguizamón MS, Campetella O, Russomando G, Almiron M, Guillen I, Ganzález Cappa SM, Frasch AC.
    J Infect Dis; 1994 Dec 19; 170(6):1570-4. PubMed ID: 7995998
    [Abstract] [Full Text] [Related]

  • 10. Trypanosoma cruzi trans-sialidase: enhancement of virulence in a murine model of Chagas' disease.
    Chuenkova M, Pereira ME.
    J Exp Med; 1995 May 01; 181(5):1693-703. PubMed ID: 7722448
    [Abstract] [Full Text] [Related]

  • 11. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA, Claser C, de Alencar BC, Tzelepis F, de Vasconcelos JR, de Oliveira G, Silvério JC, Machado AV, Lannes-Vieira J, Bruna-Romero O, Gazzinelli RT, dos Santos RR, Soares MB, Rodrigues MM.
    Vaccine; 2009 Sep 18; 27(41):5644-53. PubMed ID: 19635607
    [Abstract] [Full Text] [Related]

  • 12. The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.
    Tribulatti MV, Mucci J, Van Rooijen N, Leguizamón MS, Campetella O.
    Infect Immun; 2005 Jan 18; 73(1):201-7. PubMed ID: 15618155
    [Abstract] [Full Text] [Related]

  • 13. A functional network of intramolecular cross-reacting epitopes delays the elicitation of neutralizing antibodies to Trypanosoma cruzi trans-sialidase.
    Pitcovsky TA, Buscaglia CA, Mucci J, Campetella O.
    J Infect Dis; 2002 Aug 01; 186(3):397-404. PubMed ID: 12134236
    [Abstract] [Full Text] [Related]

  • 14. Trans-sialidase and mucins of Trypanosoma cruzi: an important interplay for the parasite.
    Giorgi ME, de Lederkremer RM.
    Carbohydr Res; 2011 Sep 06; 346(12):1389-93. PubMed ID: 21645882
    [Abstract] [Full Text] [Related]

  • 15. Circulating trans-sialidase activity and trans-sialidase-inhibiting antibodies in Trypanosoma cruzi-infected mice.
    Alcântara-Neves NM, Pontes-de-Carvalho LC.
    Parasitol Res; 1995 Sep 06; 81(7):560-4. PubMed ID: 7479647
    [Abstract] [Full Text] [Related]

  • 16. Parasite-derived trans-sialidase binds to heart tissue in Trypanosoma cruzi-infected animals.
    Alcântara-Neves NM, Ribeiro-dos-Santos R, Amor AL, Uemura H, Silva-Neto SJ, Eichinger D, Pontes-de-Carvalho L.
    Microb Pathog; 2004 Nov 06; 37(5):273-8. PubMed ID: 15519048
    [Abstract] [Full Text] [Related]

  • 17. Trypanosoma cruzi trans-sialidase as a drug target against Chagas disease (American trypanosomiasis).
    Miller BR, Roitberg AE.
    Future Med Chem; 2013 Oct 06; 5(15):1889-900. PubMed ID: 24144418
    [Abstract] [Full Text] [Related]

  • 18. Endothelial cell signalling induced by trans-sialidase from Trypanosoma cruzi.
    Dias WB, Fajardo FD, Graça-Souza AV, Freire-de-Lima L, Vieira F, Girard MF, Bouteille B, Previato JO, Mendonça-Previato L, Todeschini AR.
    Cell Microbiol; 2008 Jan 06; 10(1):88-99. PubMed ID: 17672865
    [Abstract] [Full Text] [Related]

  • 19. Trypanosoma cruzi trans-sialidase in complex with a neutralizing antibody: structure/function studies towards the rational design of inhibitors.
    Buschiazzo A, Muiá R, Larrieux N, Pitcovsky T, Mucci J, Campetella O.
    PLoS Pathog; 2012 Jan 06; 8(1):e1002474. PubMed ID: 22241998
    [Abstract] [Full Text] [Related]

  • 20. Rational drug design in parasitology: trans-sialidase as a case study for Chagas disease.
    Neres J, Bryce RA, Douglas KT.
    Drug Discov Today; 2008 Feb 06; 13(3-4):110-7. PubMed ID: 18275908
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.